Profile data is unavailable for this security.
About the company
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
- Revenue in INR (TTM)12.08bn
- Net income in INR1.28bn
- Incorporated2000
- Employees4.29k
- LocationMetropolis Healthcare LtdNh-8, Sco No. 30, Sector 15, Part IiMUMBAI 400018IndiaIND
- Phone+91 8 422801801
- Fax+91 2 256622080
- Websitehttps://www.metropolisindia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indraprastha Medical Corporation Ltd | 12.45bn | 1.24bn | 21.79bn | 2.95k | 17.58 | 4.56 | 13.29 | 1.75 | 13.52 | 13.52 | 135.76 | 52.12 | 1.95 | 66.22 | 19.66 | -- | 19.39 | 12.74 | 25.21 | 17.04 | 57.49 | 57.37 | 9.96 | 6.73 | 1.82 | 37.75 | 0.0664 | 29.13 | 13.29 | 9.57 | 43.89 | 34.26 | 32.34 | 22.98 |
| Krsnaa Diagnostics Ltd | 6.20bn | 568.40m | 22.19bn | 2.56k | 39.45 | 2.74 | 16.89 | 3.58 | 17.42 | 17.42 | 190.03 | 250.79 | 0.5953 | 4.63 | 4.97 | -- | 5.46 | 6.72 | 6.68 | 8.59 | 77.24 | 82.55 | 9.17 | 11.74 | 1.37 | 4.23 | 0.1648 | -- | 27.20 | 24.25 | -8.49 | -- | 14.21 | -- |
| Artemis Medicare Services Ltd | 8.79bn | 491.41m | 25.18bn | 1.99k | 51.96 | 5.57 | 28.14 | 2.87 | 3.54 | 3.54 | 63.29 | 33.00 | 0.9364 | 0.00 | 9.20 | 4,412,729.00 | 5.24 | -- | 6.66 | -- | -- | -- | 5.59 | 4.59 | 0.9208 | 2.95 | 0.4133 | -- | 19.14 | 9.96 | 27.32 | 19.12 | -- | -- |
| Shalby Ltd | 9.34bn | 840.80m | 29.77bn | 2.68k | 35.69 | 2.98 | 21.93 | 3.19 | 7.78 | 7.78 | 86.21 | 93.33 | 0.6464 | 2.40 | 7.44 | -- | 5.78 | 4.82 | 7.06 | 5.53 | 45.90 | 63.92 | 8.94 | 8.20 | 0.9808 | 7.78 | 0.2727 | 19.12 | 16.01 | 15.10 | 24.19 | 21.57 | 8.39 | 19.14 |
| Thyrocare Technologies Ltd | 5.72bn | 707.70m | 34.16bn | 1.65k | 48.11 | 6.48 | 29.32 | 5.97 | 13.41 | 13.41 | 108.08 | 99.52 | 0.8959 | 4.43 | 8.89 | -- | 10.89 | 18.17 | 12.55 | 20.97 | 70.85 | 69.81 | 12.15 | 19.56 | 2.55 | 26.83 | 0.0743 | 83.56 | 8.58 | 7.26 | 9.94 | -3.63 | 8.88 | -2.09 |
| Yatharth Hospital & Trauma Cre Srvcs Ltd | 6.70bn | 1.14bn | 37.02bn | -- | 28.02 | 4.23 | 25.75 | 5.52 | 15.39 | 15.39 | 91.17 | 101.84 | -- | -- | -- | -- | -- | 11.27 | -- | 13.73 | 80.14 | 78.50 | 17.08 | 12.30 | 7.47 | 41.51 | 0.0883 | -- | 28.88 | 45.78 | 74.06 | 95.81 | 3.69 | -- |
| Healthcare Global Enterprises Ltd | 19.08bn | 481.40m | 51.75bn | 5.50k | 108.28 | 6.26 | 24.00 | 2.71 | 3.43 | 3.43 | 136.12 | 59.29 | 0.7596 | 21.96 | 6.40 | -- | 1.65 | -2.26 | 2.26 | -3.05 | 53.40 | 53.78 | 2.17 | -3.50 | 0.8568 | 1.39 | 0.5956 | -- | 12.80 | 14.35 | 64.03 | -- | 0.0453 | -- |
| Vijaya Diagnostic Centre Ltd | 5.48bn | 1.19bn | 80.77bn | 2.00k | 67.92 | 12.26 | 45.73 | 14.74 | 11.59 | 11.59 | 53.44 | 64.21 | 0.5967 | 18.10 | 42.58 | -- | 13.03 | 14.10 | 14.14 | 15.54 | 88.05 | 86.41 | 21.84 | 21.20 | 2.83 | 6.83 | 0.282 | 6.66 | 19.34 | 13.37 | 40.40 | 20.97 | 7.58 | -- |
| Jupiter Life Line Hospitals Ltd | 10.70bn | 1.77bn | 83.84bn | 3.14k | 44.63 | 7.17 | 38.28 | 7.84 | 28.65 | 28.65 | 171.06 | 178.30 | 0.9436 | 9.39 | 20.79 | -- | 15.58 | -- | 17.39 | -- | 82.28 | -- | 16.51 | -- | 3.67 | 7.43 | 0.00 | -- | 19.83 | -- | 142.25 | -- | -- | -- |
| Metropolis Healthcare Ltd | 12.08bn | 1.28bn | 106.89bn | 4.29k | 83.86 | 9.75 | 47.95 | 8.85 | 24.88 | 24.88 | 235.10 | 213.97 | 0.7902 | 6.15 | 9.73 | -- | 8.40 | 13.65 | 10.11 | 16.94 | 78.79 | 75.73 | 10.64 | 14.66 | 1.13 | 8.35 | 0.152 | -- | 5.18 | 9.67 | -10.54 | 1.25 | 21.84 | -- |
| Rainbow Children's Medicare Ltd | 12.97bn | 2.17bn | 133.64bn | 3.58k | 61.58 | 10.62 | 40.45 | 10.30 | 21.38 | 21.38 | 127.78 | 124.03 | 0.6581 | 7.73 | 21.29 | -- | 11.08 | 9.89 | 11.99 | 10.96 | 87.26 | 83.51 | 16.83 | 13.80 | 4.00 | 5.36 | 0.377 | -- | 10.51 | 19.03 | 2.93 | 37.23 | 32.22 | -- |
Data as of Jul 05 2024. Currency figures normalised to Metropolis Healthcare Ltd's reporting currency: Indian Rupee INR
34.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 May 2024 | 4.24m | 8.28% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Dec 2023 | 3.37m | 6.57% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 31 May 2024 | 2.00m | 3.91% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 14 Jun 2024 | 1.73m | 3.38% |
| Grandeur Peak Global Advisors LLCas of 23 Aug 2023 | 1.45m | 2.83% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 2024 | 1.27m | 2.48% |
| First Sentier Investors (Singapore)as of 29 Feb 2024 | 1.24m | 2.42% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 1.02m | 1.99% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2023 | 808.90k | 1.58% |
| JPMorgan Asset Management (UK) Ltd.as of 07 Jun 2024 | 795.26k | 1.55% |
More ▼
Data from 31 Mar 2024 - 27 Jun 2024Source: FactSet Research Systems Inc.
